China FDA publishes online false ad sanctions on 8 local drug and device firms

China's FDA said it has sanctioned 8 firms that violated ad rules, part of a wider public campaign published online to heighten consumer safety awareness. Among those cited were Shaanxi Pharmaceutical for claiming a prescription skin treatment cured ringworm, psoriasis and eczema among other ailments within a day. Also cited was Harbin Medical Devices for a treatment that falsely claimed to ease skeletal pains within ten minutes. Release (in Chinese)